Guy Fontaine has made 15 original contributions at the inception of cardiac pacemakers in the mid-60s. He has identified ARVD by serendipity in the late 70s, published 900 scientific papers including 201 book chapters. He is in the 3 books: 216 Profiles in Cardiology since the 14th century (Hurst 2003), “500 greatest Geniuses of the 21th century” (ABI) 2005 USA, the “100 Life time of Achievement” (IBC) 2005 Cambridge UK. Reviewer of 17 journals both in clinical and basic Science. He has given 11 master lectures in China (2014). He is also working on brain and heart protection in cardiac arrest and stroke by therapeutic hypothermia.

Atrial Dysplasia, Cardiovascular diseases, cardiac arrest and stroke by therapeutic hypothermia

Marco Picichè (MD, Ph.D.) graduated with a degree in medicine from the University of Florence in 1995 and completed his cardiac surgery residency at the Tor Vergata University of Rome in 2000, both summa cum laude. He has worked as an assistant at Saint Luc Hospital, Catholic University of Louvain, Brussels (1999–2001), as a clinic head/hospital assistant at the universities of Clermont-Ferrand (2003–2004) and Montpellier (2004–2007). He held regular teaching appointments at the university of Montpellier school of medicine, obtained certification by the French Board in cardiac surgery (Paris, 2007), earned his research master in surgical science (Paris, 2007). In Canada he authored a research project on ‘‘Noncoronary collateral circulation,’’ which was submitted to the annual research competition at Québec Heart & Lung Institute, Laval University, and received the competition’s highest grant. In September 2011 he received a doctor of philosophy (Ph.D.) in therapeutic innovations from Paris-Sud University. He is the Editor in Chief of the book : « Dawn and evolution of cardiac procedures : research avenues in cardiac surgery and interventional cardiology » (Springer-Verlag publishing house). Currently he is a consultant cardiac surgeon in Italy.

Cardiac Surgery, Interventiontional cardiology

Rainer Moosdorf is working in the field of Cardiovascular Surgery since more than 35 years. He started his career as a Resident at University Hospital in Giessen in 1978. In 1990, he became a full Professor for Cardiovascular Surgery at University in Bonn and Vice Chairman of the respective department. In 1989 and 1990, he was a Researcher and Clinical Fellow at Carolinas Heart Institute in Charlotte/NC. Since 1994, he has been working at University Hospital in Marburg as a full Professor for Cardiovascular Surgery and Director of the Department. Between 2001 and 2011, he was Vice Medical Director and since 2006, Medical Director at University Hospital in Marburg. His main specialties within cardiovascular surgery are “Laser and arrhythmia surgery, endovascular procedures including TAVI´s and endovascular reconstructions of the aortic arch, reconstructive surgery of the coronaries and some types of the French correction”. As Chairman of the board of Medical Network Hessen, he is an official representative of the State of Hessen in the field of Clinical Medicine and Medical Education.

Cardiovascular Surgery, Internal Medicine, interventional cardiology

Sergey Suchkov, MD, PhD was born in 11.01.1957, a researcher-immunologist, a clinician, graduated from Astrakhan State Medical University, Russia, in 1980. Suchkov has been trained at the Institute for Medical Enzymology, The USSR Academy of Medical Sciences,National Center for Immunology (Russia), NIH, Bethesda, USA, and British Society forImmunology to cover 4 British university facilities. Since 2005, Dr Suchkov has been working as Professor of I.M. Sechenov First Moscow State Medical University and of A.I.Evdokimov Moscow State Medical & Dental University. From 2007, Suchkov is the First Vice-President and Dean of School of PPPM Politics and Management of the University of World Politics and Law. In 1991-1995, Dr Suchkov was a Scientific Secretary-in-Chief of the Editorial Board of the International Journal“Biomedical Science” (Russian Academy of Sciences and Royal Society of Chemistry, UK) and TheInternational Publishing Bureau at the Presidium of the Russian Academy of Sciences. In 1995-2005, Suchkov was a Director of the Russian-American Program in Immunology of the Eye Diseases.Dr Suchkov is a member of EPMA (European Association of Predictive, Preventive and Personalized Medicine,Brussels-Bonn), a member of the NY Academy of Sciences, a member of the Editorial Boards for Open Journal of Autoimmunity, EPMA J., Jacobs J. of Biomarkers and Personalized Medicine Universe. Dr Suchkov is known as a co-author of the Concept of post-infectious clinical and immunological syndrome, co-author of a concept of abzymes and their impact into the pathogenesis of autuimmunity conditions, and as one of the pioneers in promoting the Concept of PPPM into a practical branch of health services.

Concept of post-infectious clinical and immunological syndrome, concept of abzymes and their impact into the pathogenesis of autoimmunity conditions, Concept of PPPM into a practical branch of health services.

Fekry El Deeb is one of the first interventional Cardiologists in the Middle East. He started practicing Coronary Angioplasty at the Catharina Hospital, The Netherlands in 1986. He has worked in major hospitals such as the King Faisal Specialist Hospital and Research Center and the King Fahad National Guard hospital, Riyadh, Saudi Arabia as a Consultant and Director of the Cardiac Catheterization Laboratory. With interventional experience of more than 25 years, Dr. Fekry has performed over 10,000 different coronary, peripheral and valvular procedures.

Complex Coronary Angioplasty and Stenting, Carotid Angioplasty and Stenting, Percutaneous Valvuloplasty & All peripheral Angioplasty and Stenting

Kewal Kishan Talwar (b. 1946) is an Indian cardiologist, medical academic and writer, and a former chairman of the Medical Council of India. He is a former director of the Post Graduate Institute of Medical Education and Research (PGIMER) and is reported to have performed the first implantation of Implantable cardioverter-defibrillator (ICD) therapy in South Asia. He is also credited with the introduction of Cardiac Resynchronization Therapy in India. He is a recipient of several honors including B. C. Roy Award, the highest Indian award in the medical category.The Government of India awarded him the third highest civilian honour of the Padma Bhushan, in 2006, for his contributions to medicine.

Electrophysiology, Heart transplant

Samer Ellahham has served as Chief Quality Officer for SKMC since 2009. In his role, Dr. Ellahham has led the development of a quality and safety program that has been highly successful and visible and has been recognized internationally by a number of awards. As Chief Quality Officer and Global Healthcare Leader, he has a focus on ensuring that that implementation of this best practices leads to breakthrough improvements in clinical quality and patient safety. He Ellahham is a recognized leader in quality, safety, and the use of robust performance improvement in improving healthcare delivery. He serves on a number of US and international committees and advisory bodies. Samer Ellahham is Certified Professional in Healthcare Quality (CPHQ) by The National Association for Healthcare Quality (NAHQ). He is certified in Medical Quality (CMQ) by The American Board of Medical Quality (ABMQ). He is the recipient of the Quality Leadership Award from the World Quality Congress and Awards and the Business Leadership Excellence Award from World Leadership Congress in 2015. He is one the nominees for Safe Care magazine Person of the Year in the United States.

six sigma, change management, innovation, safety, outcomes research, risk management, safe surgery, heart failure, genetics, cardiac imaging, sports and nutrition

Roberto Colque to date is Chief of Intensive Care Unit at Sanatorio Allende Cerro in Cordoba City, Staff of Cardiology Service at Sanatorio Allende Cerro. Past President of Cardiology Society of Cordoba. Member of Heart Failure Committee of Argentine Federation of Cardiology. Abstract reviewer of World Heart Failure Congress held in 2015 and 2016. Speakers of topics in National Heart Congress from 2010-2016 about topics of Heart Failure, Acute Heart Failure, and Coronary Syndromes. Pre grade studies made in National University of cordoba at December 1987. Residence in Cardiology at Hospital Itlaiano de Cordoba until 1991. coordinator of Coronary Unit from 1992-1994. Chief Of Coronary Unit at Italian Hospital since 1994 until 2006. Head of Cardiology Service at Clinica Velez Sarsfield 2006-2013. Post graduate activity in Hospital 12 de Octubre Madrid at Heart Failure and Transplation Unit (1993) Visitor at Buenos Aires Italian Hospital 1994 specializing on Postoperative recovery unit. Visitor at Cleveland Clinic in 1995.

Heart Failure, Heart Transplantation, Cardiology

Dr Avanzas graduated in Medicine at Universidad de Navarra, Pamplona, Spain. He completed Senior House Officer posts and registrar training in Cardiology at Gregorio Marañón Hospital in Madrid, Spain. He took up a Spanish Heart Foundation Research Fellowship at Coronary Artery Research Unit, St. George´s Hospital Medical School in London and in 2002 he was appointed as Associate Research Investigator of the Cardiovascular Biology Research Centre at St. George´s Hospital in London. He was appointed as Consultant Cardiologist in Gregorio Marañón Hospital, Madrid, Spain and he also took up an Interventional Cardiology Fellowship in Hospital Universitario Central de Asturias, Oviedo, Spain. He is now senior Consultant in Invasive Cardiology in this Hospital. Dr Avanzas is author of more than 150 peer-reviewed indexed articles and invited contributions. He is also involved in teaching medical students. He is a frequent speaker at national and international meetings.

His major interests currently are in the field of coronary artery disease and biomarkers, cardiac syndrome X and interventional cardiology, particularly percutaneous valve replacement. Dr. Avanzas’s most important research interests have been the use of different markers of inflammation to predict coronary artery disease progression and cardiovascular risk. He has continued interest in this area. The other main research interests are percutaneous aortic valve replacement and conduction disturbances.

Marco Picichè (MD, Ph.D.) graduated with a degree in medicine from the University of Florence in 1995 and completed his cardiac surgery residency at the Tor Vergata University of Rome in 2000, both summa cum laude. He has worked as an assistant at Saint Luc Hospital, Catholic University of Louvain, Brussels (1999–2001), as a clinic head/hospital assistant at the universities of Clermont-Ferrand (2003–2004) and Montpellier (2004–2007). He held regular teaching appointments at the university of Montpellier school of medicine, obtained certification by the French Board in cardiac surgery (Paris, 2007), earned his research master in surgical science (Paris, 2007). In Canada he authored a research project on ‘‘Noncoronary collateral circulation,’’ which was submitted to the annual research competition at Québec Heart & Lung Institute, Laval University, and received the competition’s highest grant. In September 2011 he received a doctor of philosophy (Ph.D.) in therapeutic innovations from Paris-Sud University. He is the Editor in Chief of the book : « Dawn and evolution of cardiac procedures : research avenues in cardiac surgery and interventional cardiology » (Springer-Verlag publishing house). Currently he is a consultant cardiac surgeon in Italy.

Cardiac Surgery, Interventiontional cardiology

Dr Avanzas graduated in Medicine at Universidad de Navarra, Pamplona, Spain. He completed Senior House Officer posts and registrar training in Cardiology at Gregorio Marañón Hospital in Madrid, Spain. He took up a Spanish Heart Foundation Research Fellowship at Coronary Artery Research Unit, St. George´s Hospital Medical School in London and in 2002 he was appointed as Associate Research Investigator of the Cardiovascular Biology Research Centre at St. George´s Hospital in London. He was appointed as Consultant Cardiologist in Gregorio Marañón Hospital, Madrid, Spain and he also took up an Interventional Cardiology Fellowship in Hospital Universitario Central de Asturias, Oviedo, Spain. He is now senior Consultant in Invasive Cardiology in this Hospital. Dr Avanzas is author of more than 150 peer-reviewed indexed articles and invited contributions. He is also involved in teaching medical students. He is a frequent speaker at national and international meetings.

His major interests currently are in the field of coronary artery disease and biomarkers, cardiac syndrome X and interventional cardiology, particularly percutaneous valve replacement. Dr. Avanzas’s most important research interests have been the use of different markers of inflammation to predict coronary artery disease progression and cardiovascular risk. He has continued interest in this area. The other main research interests are percutaneous aortic valve replacement and conduction disturbances.